Attorney Daily - Your source for the most important legal news

The FDA updated the warning label on the Ortho Evra birth control patch after results of a new study found woman using the patch were twice as likely to develop blood clots, than those taking birth control pills. Johnson & Johnson is already facing over 500 suits from women who claim Ortho Evra caused serious side effects including blood clots, pulmonary embolism, deep venous thrombosis, stroke, heart attack, paralysis and even death. The new warning could spur a new round of lawsuits against McNeil Pharmaceuticals, a division of Johnson & Johnson.

The new study validates an investigation conducted last year by the Associated Press, which found high rates of blood clots in women using the patch. Last November, the FDA updated the label on Ortho Evra to alert women that using the patch exposes them to about 60 percent more estrogen than using birth-control pills. Johnson & Johnson has said in the past that blood clots associated with Ortho Evra are rare, and the risk is similar to those of oral contraceptives.
(more…)

A Louisiana man filed a lawsuit in U.S. District Court against Eli Lilly and Co., claiming he developed diabetes as a result of using the popular atypical antipsychotic drug Zyprexa. The man took Zyprexa for two years and developed severe diabetes. The lawsuit argues that Eli Lilly did not give proper warning that the drug could be linked to diabetes and other serious side effects.
(more…)

Men being treated for prostate cancer are commonly given GnRH (gonadotropin-releasing hormone) hormone therapy injections to block the production of testosterone. While the use of these drugs has become a routine part of prostate cancer treatment, a new Harvard study finds that the treatment increases the risk of heart attack and diabetes, and does not prolong life expectancy. The findings from this study will be published in the September 20 issue of the Journal of Clinical Oncology.

(more…)